Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning

Keyphrases

• Atomoxetine 100%
• Attention Deficit Hyperactivity Disorder 33%
• Attention-deficit Hyperactivity Disorder Symptoms 16%
• C57BL 16%
• Cell Signaling 16%
• Chronic Nicotine 33%
• Cognitive Deficits 33%
• Cognitive Symptoms 33%
• Conditioned Stimulus 50%
• Contextual Fear Conditioning 100%
• Continuous Treatment 16%
• Footshock 16%
• Intermittent Smokers 16%
• Minipump 16%
• Neural Correlates 16%
• Nicotine 50%
• Nicotine Withdrawal 100%
• Noradrenergic 16%
• Osmotic Minipump 16%
• Signaling Cascades 16%
• Training Set 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Atomoxetine 100%
• Attention Deficit Disorder 60%
• C57BL 6 Mouse 20%
• Cognitive Defect 40%
• Mouse 80%
• Noradrenalin 20%
• Norepinephrine Reuptake Inhibitor 20%
• Sodium Chloride 20%
• Symptom 80%
• Withdrawal Syndrome 20%

Neuroscience

• Atomoxetine 100%
• Attention Deficit Hyperactivity Disorder 60%
• Cell Signaling 20%
• Cognitive Disorders 40%
• Fear Conditioning 100%
• Norepinephrine 20%
• Norepinephrine Reuptake Inhibitor 20%
• Withdrawal Syndrome 20%